Stockscreener 앱 받기
6.40
2.14%
-0.14
전일 마감가:
$6.54
열려 있는:
$6.45
하루 거래량:
2,611
Relative Volume:
0.08
시가총액:
$88.66M
수익:
$49.98M
순이익/손실:
$-9.64M
주가수익비율:
-9.0141
EPS:
-0.71
순현금흐름:
$-4.86M
1주 성능:
-0.31%
1개월 성능:
-6.30%
6개월 성능:
-12.81%
1년 성능:
+40.97%
1일 변동 폭
$6.35
$6.47
1주일 범위
$6.3201
$6.8907
52주 변동 폭
$3.75
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
명칭
Champions Oncology Inc
전화
410-369-0365
주소
855 N. WOLFE STREET, BALTIMORE, NJ
CSBR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.43 | 90.18M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.04 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.31 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.94 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-12 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-11-18 | 개시 | The Benchmark Company | Speculative Buy |
Champions Oncology Inc 주식(CSBR)의 최신 뉴스
What moving averages say about Champions Oncology Inc.July 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Will Champions Oncology Inc. bounce back from current support2025 Year in Review & Daily Stock Trend Reports - newser.com
Will Champions Oncology Inc. stock see insider buyingMarket Movers & Weekly High Potential Stock Alerts - newser.com
Is Champions Oncology Inc. showing signs of accumulationInflation Watch & Fast Entry Momentum Alerts - newser.com
Sentiment analysis tools applied to Champions Oncology Inc.Market Risk Summary & Technical Buy Zone Confirmations - newser.com
How Champions Oncology Inc. (2I3) stock reacts to stronger dollar2025 Momentum Check & Free Community Consensus Stock Picks - newser.com
3 Dividend Champion Stocks I'm Watching in 2025 - sharewise.com
Will Champions Oncology Inc. (2I3) stock benefit from sector leadershipJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
Will Champions Oncology Inc. (2I3) stock keep raising dividendsJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
How to interpret RSI for Champions Oncology Inc. stockWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Relative strength of Champions Oncology Inc. in sector analysisWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
Volatility clustering patterns for Champions Oncology Inc.Profit Target & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Champions Oncology Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Why Champions Oncology Inc. (2I3) stock could rally stronglyEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Is Champions Oncology Inc. stock ready for breakout2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Can Champions Oncology Inc. stock maintain operating marginsForecast Cut & AI Forecast Swing Trade Picks - newser.com
Visual analytics tools that track Champions Oncology Inc. performanceDividend Hike & Precise Entry and Exit Recommendations - newser.com
Best data tools to analyze Champions Oncology Inc. stockWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Institutional scanner results for Champions Oncology Inc.Trade Volume Summary & Verified Chart Pattern Signals - newser.com
Is Champions Oncology Inc. a candidate for recovery playPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Why Champions Oncology Inc. stock appeals to analysts2025 Pullback Review & AI Driven Stock Reports - newser.com
What drives Champions Oncology Inc 2I3 stock priceSector ETF Performance & Double Or Triple Capital - earlytimes.in
Champions Oncology Inc Stock Analysis and ForecastStock Price Divergence & Free Phenomenal Investment Performance - earlytimes.in
Champions Oncology Inc 2I3 Stock Analysis and ForecastGlobal Trade Effects & Outstanding Investment Returns - earlytimes.in
13% of Sales Support Breast Cancer Research: Athleta x Kristin Juszczyk Launch Limited Edition Sports Bra - Stock Titan
Champions Oncology Inc (CSBR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
자본화:
|
볼륨(24시간):